We thus focused our analysis on those patients (n = 50), and neither plasma cell-free DNA concentrations, MPO–DNA, nor H3Cit levels were different between ARDS patients who later developed PE (n = 18) and those who did not (n = 32) (Figures 4D–F). This evidence concerns the gene MPO and acute respiratory distress syndrome.